期刊文献+

FoxM1基因表达与甲状腺乳头状癌TPC-1细胞活性及侵袭性关系的研究 被引量:3

Correlation of FoxM1 with the activity and invasiveness of papillary thyroid carcinoma cell TPC-1
原文传递
导出
摘要 目的 研究FoxM1基因表达水平对甲状腺乳头状癌(papillary thyroid carcinoma,PTC)细胞活性和侵袭性有无影响,探讨FoxM1与PTC疾病的相关性.方法 分别用hFoxM1-RNA干扰和硫链丝菌素处理PTC TPC-1细胞,观察处理后的癌细胞与未经处理的癌细胞在细胞活性、侵袭能力、迁移能力方面的变化,并使用Real-time PCR检测各组细胞中FoxM1基因的表达水平,观察硫链丝菌素对FoxM1基因表达水平的影响.结果 在TPC-1细胞中,使用hFoxM 1-RNA干扰和硫链丝菌素处理均能使细胞活性明显下降(P<0.05),用2种方法处理后,细胞侵袭能力分别降低了约29.2%及38.63%,细胞迁移能力分别降低了约46.0%及47.5%,且PCR结果表明,hFoxM1-RNA干扰和硫链丝菌素处理均明显抑制TPC-1细胞中FoxM1基因mRNA的表达,分别抑制55%及38%.结论 FoxM1能促进PTC细胞的侵袭转移,其作为潜在的肿瘤标志物值得关注,而硫链丝菌素能抑制肿瘤细胞中FoxM1的表达. Objective To study correlation of FoxM1 expression level with the activity and invasiveness in papillary thyroid carcinoma (PTC)cell line TPC-1.Methods TPC-1 cells were treated by hFoxM1-RNA interference or thiostrepton.The changes of cell activity,invasiveness and migration of treated TPC-1 cells were observed.Real-time PCR was used to measured the expression of FoxM1 in TPC-1 cells or thiostrepton treated TPC-1 cells.Results In TPC-1 cells,either hFoxM1-RNA interference or thiostrepton significantly inhibited the cell activity.The cell invasiveness decreased 29.2% or 38.63% and migration decreased 46.0% or 47.5% after the treatment of hFoxM1-RNA interference or thiostrepton.Treatment of hFoxM1-RNA interference or thiostrepton significantly inhibited mRNA level of FoxM1 in TPC-1 cells,the inbition was 55% or 38%.Conclusions FoxM1 can promote the invasion and metastasis of PTC cells.It suggests that FoxM1 can be used as a potential tumor marker,and thiostrepton can inhibit FoxM1 expression in tumor cells.
出处 《中华内分泌外科杂志》 CAS 2014年第1期33-37,52,共6页 Chinese Journal of Endocrine Surgery
基金 浦东新区卫生系统优秀青年医学人才资助项目(PWRq2012-12)
关键词 甲状腺乳头状癌 FoxM1基因 侵袭性 Papillary thyroid carcinoma FoxM1 Invasiveness
  • 相关文献

参考文献9

  • 1Wang IC,Meliton L,Tretiakova M,et al.Transgenic expression of the forkhead box M1 transcription factor induces formation of lung tumors[J].Oncogene,2008,27(30):4137-4149.
  • 2Myatt SS,Lam EW.The emerging roles of forkhead box(Fox) proteins in cancer[J].Nat Rev Cancer,2007,7 (11):847-859.
  • 3Ahmad A,Wang Z,Kong D,et al.FoxMl down regulation leads to inhibition of proliferation,migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors[J].Breast Cancer Res Treat,2010,122(2):337-346.
  • 4Bhat UG,Halasi M,Gartel AL.Thiazole antibiotics target FoxM1 and induce apoptosis in human cancer cells[J].PLoS One,2009,4(5):e5592.
  • 5Guan H,Ji M,Bao R,et al.Association of high iodine intake with the T1799A BRAF mutation in papillary thyroid cancer[J].J Clin Endocrinol Metab,2009,94(5):1612-1617.
  • 6王玉龙,王久存,李端树,朱永学,吴毅,嵇庆海.甲状腺乳头状癌的基因重排分析[J].中华耳鼻咽喉头颈外科杂志,2007,42(12):929-933. 被引量:3
  • 7Kwok JM,Myatt SS,Marsen CM,et al.Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box Ml expression[J].Mol Cancer Ther,2008,7(7):2022-2032.
  • 8Ahmed M,Uddin S,Hussain AR,et al.FoxM1 and its association with matrix metalloproteinases(MMP) signaling pathway in papillary thyroid carcinoma[J].J Clin Endocrinol Metab,2012,97(1):E1-E13.
  • 9黄培,李道明,黄器伟,宋一民,庞霞.高迁移率族蛋白B1、基质金属蛋白酶-9和血管内皮生长因子-C在甲状腺乳头状癌中的表达及意义[J].中华内分泌外科杂志,2013,7(4):265-268. 被引量:6

二级参考文献18

  • 1郑荣秀,方佩华,吕枚.甲状腺乳头状癌患者ret基因重排突变[J].中华内分泌代谢杂志,2005,21(2):106-109. 被引量:9
  • 2朱晓丽,周晓燕,朱雄增.甲状腺乳头状癌中BRAF^(V599E)点突变与RET/PTC融合基因的检测[J].中华病理学杂志,2005,34(5):270-274. 被引量:30
  • 3李焱,蒋勇,史立群,史爱学,彭亦良,梁后杰.HMGB1和VEGF-C/D在结肠癌组织中的表达及与淋巴结转移之间的关系[J].第三军医大学学报,2006,28(11):1237-1239. 被引量:9
  • 4Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin, 2006, 56:106-130.
  • 5Hundahl SA, Fleming ID, Fremgen AM, et al. A National Cancer Data Base report on 53 856 cases of thyroid carcinoma treated in the United States, 1985-1995. Cancer, 1998, 83:2638-2648.
  • 6Tallini G, Asa SL RET oncogene activation in papillary thyroid carcinoma. Adv Anat Pathol, 2001, 8:345-354.
  • 7Kuo CS, Lin CY, Hsu CW, et al. Low frequency of rearrangement of TRK protooncogene in Chinese thyroid tumors. Endocrine,2000, 13:341-344.
  • 8Rabes HM, Demidchik EP, Sidorow JD, et al. Pattern of radiation-induced RET and NTRK1 rearrangements in 191 postchemobyl papillary thyroid carcinomas : biological, phenotypic, and clinical implications. Clin Cancer Res, 2000, 6 : 1093-1103.
  • 9Puxeddu E, Zhao G, Stringer JR, et al. Characterization of novel non-clonal intrachromosomal rearrangements between the H4 and PTEN genes (H4/PTEN) in human thyroid cell lines and papillary thyroid cancer specimens. Mutat Res, 2005, 570: 17-32.
  • 10Liu RT, Chou FF, Wang CH, et al. Low prevalence of RET rearrangements ( RET/PTC1 , RET/PTC2, RET/PTC3, and ELKS-RET) in sporadic papillary thyroid carcinomas in Taiwan Chinese. Thyroid, 2005, 15:326-335.

共引文献7

同被引文献38

  • 1王玉龙,王久存,李端树,朱永学,吴毅,嵇庆海.甲状腺乳头状癌的基因重排分析[J].中华耳鼻咽喉头颈外科杂志,2007,42(12):929-933. 被引量:3
  • 2Occhi G, Barollo S, Regazzo D, et al. A constitutive active MAPK/ ERK pathway due to BRAFv6 positively regulates AHR pathway in PTC. Oncotarget, 2015, 6(31): 32104-32114.
  • 3Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973 - 2002. lAMA, 2006, 295 ( 18): 2164-2167.
  • 4Ramakrishna S, Kim IM, Petrovic V, et al. Myocardium defects and ventricular hypoplasia in mice homozygous null for the Forkhead Box M1 transcription factor. Dev Dyn, 2007, 236(4): 1000-1013.
  • 5Brezillon N, Lambert-Blot M, Morosan S, et al. Transplanted hepato- cytes over-expressing FoxM1B efficiently repopulate chronically injured mouse liver independent of donor age. Mol Ther, 2007, 15(9): 1710-1715.
  • 6Korver W, Roose J, Heinen K, et al. The human Trident/HFH-11/FKHL16 gene: structure, localization, and promoter characterization. Genomics, 1997, 46(3): 435-442.
  • 7Yau C, Meyer L, Benz S, et al. FOXM1 cistrome predicts breast cancer metastatic outcome better than FOXM1 expression levels or tumor proliferation index. Breast Cancer Res Treat, 2015, 154(1): 2332.
  • 8Zhang HG, Xu XW, Shi XP, et al. Overexpression of forkhead box protein M1 (FOXM1) plays a critical role in colorectal cancer. Clin Transl Oncol, 2015 Sep 14.
  • 9Guan H, Ji M, Bao R, et al. Association of high iodine intake with the T1799A BRAF mutation in papillary thyroid cancer. J Clin 18ndocrinol Metab, 2009, 94(5): 1612-1617.
  • 10Zou M, Baitei EY, Alzahrani AS, et al. Concomitant RAS, RET/ PTC, or BRAF mutations in advanced stage of papillary thyroid carcinoma. Thyroid, 2014, 24(8): 1256-1266.

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部